Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
- PMID: 19641190
- DOI: 10.1182/blood-2009-03-208397
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
Abstract
We report 2 novel, cryptic chromosomal abnormalities in precursor B-cell acute lymphoblastic leukemia (BCP-ALL): a translocation, either t(X;14)(p22;q32) or t(Y;14)(p11;q32), in 33 patients and an interstitial deletion, either del(X)(p22.33p22.33) or del(Y)(p11.32p11.32), in 64 patients, involving the pseudoautosomal region (PAR1) of the sex chromosomes. The incidence of these abnormalities was 5% in childhood ALL (0.8% with the translocation, 4.2% with the deletion). Patients with the translocation were older (median age, 16 years), whereas the patients with the deletion were younger (median age, 4 years). The 2 abnormalities result in deregulated expression of the cytokine receptor, cytokine receptor-like factor 2, CRLF2 (also known as thymic stromal-derived lymphopoietin receptor, TSLPR). Overexpression of CRLF2 was associated with activation of the JAK-STAT pathway in cell lines and transduced primary B-cell progenitors, sustaining their proliferation and indicating a causal role of CRLF2 overexpression in lymphoid transformation. In Down syndrome (DS) ALL and 2 non-DS BCP-ALL cell lines, CRLF2 deregulation was associated with mutations of the JAK2 pseudokinase domain, suggesting oncogenic cooperation as well as highlighting a link between non-DS ALL and JAK2 mutations.
Similar articles
-
Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.Ann Hematol. 2021 Aug;100(8):2031-2041. doi: 10.1007/s00277-021-04574-0. Epub 2021 Jun 22. Ann Hematol. 2021. PMID: 34159401
-
t(X;14)(p22;q32)/t(Y;14)(p11;q32) CRLF2-IGH translocations from human B-lineage ALLs involve CpG-type breaks at CRLF2, but CRLF2/P2RY8 intrachromosomal deletions do not.Blood. 2010 Sep 16;116(11):1993-4. doi: 10.1182/blood-2010-05-286492. Blood. 2010. PMID: 20847213 Free PMC article. No abstract available.
-
Correlation of the surface expression of thymic stromal lymphopoietin receptor with the presence of CRLF2 gene rearrangements in children with B-lineage acute lymphoblastic leukemia.Int J Lab Hematol. 2023 Jun;45(3):337-343. doi: 10.1111/ijlh.14028. Epub 2023 Feb 7. Int J Lab Hematol. 2023. PMID: 36748719
-
Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers?Blood. 2010 Feb 25;115(8):1490-9. doi: 10.1182/blood-2009-09-235986. Epub 2009 Dec 30. Blood. 2010. PMID: 20042721 Review.
-
CRLF2 and JAK2 in B-progenitor acute lymphoblastic leukemia: a novel association in oncogenesis.Cancer Res. 2010 Oct 1;70(19):7347-52. doi: 10.1158/0008-5472.CAN-10-1528. Epub 2010 Aug 31. Cancer Res. 2010. PMID: 20807819 Free PMC article. Review.
Cited by
-
Genomic profiling of B-progenitor acute lymphoblastic leukemia.Best Pract Res Clin Haematol. 2011 Dec;24(4):489-503. doi: 10.1016/j.beha.2011.09.004. Epub 2011 Nov 6. Best Pract Res Clin Haematol. 2011. PMID: 22127311 Free PMC article. Review.
-
Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia.Blood. 2021 Dec 9;138(23):2313-2326. doi: 10.1182/blood.2020006846. Blood. 2021. PMID: 34110416 Free PMC article.
-
Oncogenic Enhancers in Leukemia.Blood Cancer Discov. 2024 Sep 3;5(5):303-317. doi: 10.1158/2643-3230.BCD-23-0211. Blood Cancer Discov. 2024. PMID: 39093124 Review.
-
Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.Haematologica. 2019 Jul;104(7):1396-1406. doi: 10.3324/haematol.2018.204974. Epub 2019 Jan 10. Haematologica. 2019. PMID: 30630978 Free PMC article.
-
A novel approach for direct detection of the IGH::CRLF2 gene fusion by fluorescent in situ hybridization.Mol Cytogenet. 2023 Aug 13;16(1):19. doi: 10.1186/s13039-023-00652-2. Mol Cytogenet. 2023. PMID: 37574565 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous